Wright, Grace C. http://orcid.org/0000-0002-6043-7277
Mysler, Eduardo http://orcid.org/0000-0002-8993-0313
Kwok, Kenneth
Cadatal, Mary Jane
Germino, Rebecca
Yndestad, Arne
Kinch, Cassandra D. http://orcid.org/0000-0002-2712-1668
Ogdie, Alexis
Funding for this research was provided by:
Pfizer
Article History
Received: 3 January 2024
Accepted: 3 May 2024
First Online: 3 July 2024
Declarations
:
: Grace C. Wright has acted as a consultant for AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Exagen, GSK, Janssen, Novartis, Pfizer Inc, Sanofi, Scipher Medicine, and UCB; is an officer/board member for the Association of Women in Rheumatology; and is a member of the speakers’ bureau for AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Novartis, Sanofi, and UCB. Eduardo Mysler has received grant/research support from Eli Lilly, Janssen, Pfizer Inc, and Roche; and is a member of the speakers’ bureau for AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Janssen, Pfizer Inc, Roche, and Sanofi. Kenneth Kwok, Mary Jane Cadatal, and Arne Yndestad are employees and stockholders of Pfizer Inc. Rebecca Germino and Cassandra D. Kinch were employees and stockholders of Pfizer Inc at the time of this work. Alexis Ogdie has acted as a consultant for AbbVie, Amgen, Bristol Myers Squibb, Celgene, CorEvitas, Eli Lilly, Gilead, GSK, Janssen, Novartis, Pfizer Inc, and UCB; and has received grant/research support from AbbVie, Amgen, Janssen, Novartis, and Pfizer Inc.
: Each study was conducted in accordance with the Declaration of Helsinki, International Council for Harmonisation Guidelines for Good Clinical Practice and local country regulations, and approved by the Institutional Review Board and Independent Ethics Committee at each center. Patients provided written informed consent. No further ethical approval was required for this post hoc analysis in accordance with the policies of our institutions.